oxybutynin has been researched along with Enuresis in 53 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Enuresis: Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).
| Excerpt | Relevance | Reference |
|---|---|---|
| "We prospectively evaluated the efficacy of a combination of desmopressin and oxybutynin for treating children with nocturnal enuresis, compared to the single drugs imipramine and desmopressin." | 9.11 | Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial. ( Lee, HJ; Lee, JE; Lee, T; Suh, HJ, 2005) |
| "We conclude that combination of imipramine with oxybutynin is a safe and new choice in the treatment of nocturnal enuresis." | 9.09 | Combination therapy of imipramine with oxybutynin in children with enuresis nocturna. ( Ceylan, S; Dayanç, M; Kibar, Y; Tahmaz, L; Yildirim, I, 2000) |
| "A review of the scarce literature concerning oxybutynin treatment for nocturnal enuresis reveals that its success is greatest when enuresis is combined with daytime incontinence." | 9.09 | Oxybutynin, desmopressin and enuresis. ( Nevéus, T, 2001) |
| " After a 2-week observation period, 66 patients with primary monosymptomatic enuresis were treated with DDAVP, 30 micrograms/day intranasally, for 6 weeks, 48 patients with enuresis and voiding dysfunction were randomly assigned to a protocol with oxybutynin alone or oxybutynin plus DDAVP." | 9.08 | Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. ( Arena, F; Artibani, W; Biraghi, M; Caione, P; Chendi, D; Chiozza, ML; Cigna, RM; De Grazia, E; De Lisa, A; Fano, M; Formica, P; Garofalo, S; Gramenzi, R; Lanza, P; Lanza, T; Maffei, S; Manieri, C; Merlini, E; Miano, L; Nappo, S; Pagliarulo, A; Paolini Paoletti, F; Pau, AC; Porru, D; von Heland, M, 1997) |
| "The effectiveness of oxybutynin in the treatment of primary enuresis was evaluated in a double-blind study." | 9.06 | Oxybutynin efficacy in the treatment of primary enuresis. ( Lovering, JS; McKendry, JB; Tallett, SE, 1988) |
| "00 D developed esotropia while being treated with oxybutynin for enuresis." | 7.74 | Oxybutynin-associated esotropia. ( Harding, A; Kowal, L; Wong, EY, 2007) |
| "Thirty-six patients with enuresis who were non-responsive to imipramine were urodynamically assessed and subsequently treated with oxybutynin hydrochloride (HCl)." | 7.70 | Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna--a clinical and urodynamic study. ( Arikan, N; Dinçel, C; Koşar, A, 1999) |
| "Sixty-three children with persistent nocturnal enuresis were urodynamically assessed and subsequently treated with oxybutynin chloride." | 7.68 | Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis. ( Alken, P; Jünemann, KP; Köhrmann, KU; Persson-Jünemann, C; Seemann, O, 1993) |
| "Enuresis is identified as voluntary or involuntary leakage of urine for at least three consecutive months in the daytime and/or nighttime on clothes for children older than five." | 5.62 | Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis. ( Çakıroğlu, B; Gözüküçük, A; Kılıç, M, 2021) |
| "The association between desmopressin and oxybutynin is the therapeutic strategy with the highest probability of success in the treatment of enuresis in children and adolescents compared with placebo (relative risk [RR] 2." | 5.41 | Eficácia E Custo-Utilidade De Intervenções Para O Tratamento Da Enurese Em Crianças E Adolescentes Sob A Perspectiva Do Sistema Único De Saúde Brasileiro: Effectiveness and Cost-Utility of Interventions for Enuresis Treatment in Children and Adolescents F ( Jaguaribe de Lima, AM; Lemos, A; Marcolino, MAZ; Moretti, E, 2023) |
| " Combination therapy with desmopressin and oxybutynin is a feasible, safe and effective treatment for nocturnal enuresis in these children." | 5.12 | Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder. ( Abu-Arafeh, W; Chertin, B; Farkas, A; Koulikov, D; Mor, Y; Shenfeld, OZ, 2007) |
| "We prospectively evaluated the efficacy of a combination of desmopressin and oxybutynin for treating children with nocturnal enuresis, compared to the single drugs imipramine and desmopressin." | 5.11 | Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial. ( Lee, HJ; Lee, JE; Lee, T; Suh, HJ, 2005) |
| "The study included 34 children with refractory MNE; all were treated > 5 years earlier for their MNE using a combined stepwise approach, consisting of retention control training, oxybutynin and an enuresis alarm." | 5.11 | Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity. ( de Wachter, S; Vermandel, A; Wyndaele, JJ, 2005) |
| "A review of the scarce literature concerning oxybutynin treatment for nocturnal enuresis reveals that its success is greatest when enuresis is combined with daytime incontinence." | 5.09 | Oxybutynin, desmopressin and enuresis. ( Nevéus, T, 2001) |
| " After a 2-week observation period, 66 patients with primary monosymptomatic enuresis were treated with DDAVP, 30 micrograms/day intranasally, for 6 weeks, 48 patients with enuresis and voiding dysfunction were randomly assigned to a protocol with oxybutynin alone or oxybutynin plus DDAVP." | 5.08 | Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin. ( Arena, F; Artibani, W; Biraghi, M; Caione, P; Chendi, D; Chiozza, ML; Cigna, RM; De Grazia, E; De Lisa, A; Fano, M; Formica, P; Garofalo, S; Gramenzi, R; Lanza, P; Lanza, T; Maffei, S; Manieri, C; Merlini, E; Miano, L; Nappo, S; Pagliarulo, A; Paolini Paoletti, F; Pau, AC; Porru, D; von Heland, M, 1997) |
| " The generation of awakening response is thought to be the most important result of imipramine directly concerned with its clinical effect on enuresis type IIa." | 5.08 | Effects of systematic treatment based on overnight simultaneous monitoring of electroencephalography and cystometry. ( Imada, N; Kawauchi, A; Tanaka, Y; Watanabe, H; Yamao, Y, 1998) |
| "00 D developed esotropia while being treated with oxybutynin for enuresis." | 3.74 | Oxybutynin-associated esotropia. ( Harding, A; Kowal, L; Wong, EY, 2007) |
| " We report a 4-year-old girl who presented with acute bilateral blindness, a focal seizure and hypertension 10 days after commencing oxybutynin to treat enuresis." | 3.74 | Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment. ( Branson, JA; Dale, RC, 2008) |
| "We evaluated combination treatment with desmopressin and oxybutynin in patients with enuresis who did not respond to desmopressin monotherapy." | 3.73 | The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis. ( Kovács, L; Radvanska, E; Rittig, S, 2006) |
| "To evaluate children with refractory monosymptomatic nocturnal enuresis to determine whether detrusor overactivity (DOA) plays a role in 4 weeks of unsuccessful treatment with retention control training (RCT); whether an increase in bladder capacity can eventually be obtained by RCT plus oxybutynin; and whether the increase in capacity is the primary key to success." | 3.71 | Value of increase in bladder capacity in treatment of refractory monosymptomatic nocturnal enuresis in children. ( De Moerloose, K; De Wachter, S; Vermandel, A; Wyndaele, JJ, 2002) |
| "Sixty-three children with persistent nocturnal enuresis were urodynamically assessed and subsequently treated with oxybutynin chloride." | 3.68 | Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis. ( Alken, P; Jünemann, KP; Köhrmann, KU; Persson-Jünemann, C; Seemann, O, 1993) |
| "Nocturnal enuresis is a problem that affects many children and their families." | 2.42 | Nocturnal enuresis: medical management. ( Ferrer, FA; Mammen, AA, 2004) |
| "Primary nocturnal enuresis is one of the most frequent complaints in paediatric and urologic practice." | 2.42 | Comparative tolerability of drug treatment for nocturnal enuresis in children. ( Eggert, P; Müller, D; Roehr, CC, 2004) |
| "The physician's role in treating enuresis is first to rule out structural causes for enuresis." | 2.39 | Diagnosis and management of nocturnal enuresis. ( Gandhi, KK, 1994) |
| "Enuresis is identified as voluntary or involuntary leakage of urine for at least three consecutive months in the daytime and/or nighttime on clothes for children older than five." | 1.62 | Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis. ( Çakıroğlu, B; Gözüküçük, A; Kılıç, M, 2021) |
| "We present our experience in the treatment of enuresis at the Pediatric Urology Outpatient Office over a period of four years." | 1.33 | Nocturnal enuresis in children. A four-year experience in outpatient clinics of pediatric urology. ( Balaxis, E; Kalaitzis, C; Rombis, V; Touloupidis, S; Triantafyllidis, A, 2005) |
| "Nocturnal enuresis is an innocent but distressing disorder occurring in many children." | 1.31 | [Monosymptomatic nocturnal enuresis: disease or complaint?]. ( Otto-Buczkowska, E; Szirer, G, 2000) |
| "Nocturnal enuresis is a common childhood disorder." | 1.31 | Combined pharmacotherapy for nocturnal enuresis. ( Fujinaga, S; Kaneko, K; Ohtomo, Y; Shimizu, T; Yamashiro, Y, 2001) |
| " In all cases patients had been treated according to a normal dosage regimen." | 1.30 | [Neuropsychiatric adverse effects attributed to use of oxybutynin]. ( Kwee-Zuiderwijk, WJ; Stricker, BH; t'Veld, BA; van Puijenbroek, EP, 1998) |
| " More rigid dosage schedules with longer time intervals between doses are needed." | 1.28 | [Overdose of anticholinergic agents and confusional syndrome]. ( Choulot, JJ; Mensire, A; Saint Martin, J, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (9.43) | 18.7374 |
| 1990's | 15 (28.30) | 18.2507 |
| 2000's | 28 (52.83) | 29.6817 |
| 2010's | 2 (3.77) | 24.3611 |
| 2020's | 3 (5.66) | 2.80 |
| Authors | Studies |
|---|---|
| Moretti, E | 2 |
| Barbosa, L | 1 |
| da Silva, IB | 1 |
| de Lima, AMJ | 1 |
| Lemos, A | 2 |
| Marcolino, MAZ | 1 |
| Jaguaribe de Lima, AM | 1 |
| Gözüküçük, A | 1 |
| Kılıç, M | 1 |
| Çakıroğlu, B | 1 |
| Rittig, N | 1 |
| Hagstroem, S | 1 |
| Mahler, B | 1 |
| Kamperis, K | 1 |
| Siggaard, C | 1 |
| Mikkelsen, MM | 1 |
| Bower, WF | 1 |
| Djurhuus, JC | 1 |
| Rittig, S | 2 |
| Ellsworth, PI | 1 |
| De Wachter, S | 2 |
| Vermandel, A | 2 |
| De Moerloose, K | 1 |
| Wyndaele, JJ | 2 |
| Bolduc, S | 1 |
| Upadhyay, J | 1 |
| Payton, J | 1 |
| Bägli, DJ | 1 |
| McLorie, GA | 1 |
| Khoury, AE | 1 |
| Farhat, W | 1 |
| Listernick, R | 1 |
| Mammen, AA | 1 |
| Ferrer, FA | 1 |
| Müller, D | 1 |
| Roehr, CC | 1 |
| Eggert, P | 1 |
| Lee, T | 1 |
| Suh, HJ | 1 |
| Lee, HJ | 1 |
| Lee, JE | 1 |
| Rombis, V | 1 |
| Triantafyllidis, A | 1 |
| Balaxis, E | 1 |
| Kalaitzis, C | 1 |
| Touloupidis, S | 1 |
| Radvanska, E | 1 |
| Kovács, L | 1 |
| Brudermanns, B | 1 |
| Sehgal, R | 1 |
| Paul, P | 1 |
| Mohanty, NK | 1 |
| Chertin, B | 1 |
| Koulikov, D | 1 |
| Abu-Arafeh, W | 1 |
| Mor, Y | 1 |
| Shenfeld, OZ | 1 |
| Farkas, A | 1 |
| Diaz Saldano, D | 1 |
| Chaviano, AH | 1 |
| Maizels, M | 2 |
| Yerkes, EB | 1 |
| Cheng, EY | 1 |
| Losavio, J | 1 |
| Porten, SP | 1 |
| Sullivan, C | 1 |
| Zebold, KF | 1 |
| Hagerty, J | 1 |
| Kaplan, WE | 1 |
| Wong, EY | 1 |
| Harding, A | 1 |
| Kowal, L | 1 |
| Branson, JA | 1 |
| Dale, RC | 1 |
| Noe, HN | 1 |
| Cochat, P | 1 |
| Meunier, P | 1 |
| Di Maio, M | 1 |
| Gandhi, KK | 1 |
| Rushton, HG | 1 |
| Persson-Jünemann, C | 1 |
| Seemann, O | 1 |
| Köhrmann, KU | 1 |
| Jünemann, KP | 1 |
| Alken, P | 1 |
| Steele, BT | 1 |
| Frankenburg, FR | 1 |
| Kando, JC | 1 |
| Centorrino, F | 1 |
| Gilbert, JM | 1 |
| Caione, P | 1 |
| Arena, F | 1 |
| Biraghi, M | 2 |
| Cigna, RM | 1 |
| Chendi, D | 1 |
| Chiozza, ML | 2 |
| De Lisa, A | 1 |
| De Grazia, E | 1 |
| Fano, M | 1 |
| Formica, P | 1 |
| Garofalo, S | 1 |
| Gramenzi, R | 1 |
| von Heland, M | 1 |
| Lanza, P | 1 |
| Lanza, T | 1 |
| Maffei, S | 1 |
| Manieri, C | 1 |
| Merlini, E | 1 |
| Miano, L | 1 |
| Nappo, S | 1 |
| Pagliarulo, A | 1 |
| Paolini Paoletti, F | 1 |
| Pau, AC | 1 |
| Porru, D | 1 |
| Artibani, W | 1 |
| Hjälmås, K | 2 |
| von Gontard, A | 2 |
| Lehmkuhl, G | 1 |
| Kawauchi, A | 1 |
| Imada, N | 1 |
| Tanaka, Y | 1 |
| Yamao, Y | 1 |
| Watanabe, H | 1 |
| t'Veld, BA | 1 |
| Kwee-Zuiderwijk, WJ | 1 |
| van Puijenbroek, EP | 1 |
| Stricker, BH | 1 |
| Plebani, M | 1 |
| Scaccianoce, C | 1 |
| Zacchello, G | 1 |
| Koşar, A | 1 |
| Arikan, N | 1 |
| Dinçel, C | 1 |
| Läckgren, G | 1 |
| van Gool, J | 1 |
| de Gennaro, M | 1 |
| Lottmann, H | 1 |
| Terho, P | 1 |
| Schulman, SL | 1 |
| Colish, Y | 1 |
| von Zuben, FC | 1 |
| Kodman-Jones, C | 1 |
| Otto-Buczkowska, E | 1 |
| Szirer, G | 1 |
| Tahmaz, L | 1 |
| Kibar, Y | 1 |
| Yildirim, I | 1 |
| Ceylan, S | 1 |
| Dayanç, M | 1 |
| Rodríguez do Forno, A | 1 |
| Ariceta Iraola, G | 1 |
| Robson, WL | 1 |
| Evans, JH | 2 |
| Kaneko, K | 1 |
| Fujinaga, S | 1 |
| Ohtomo, Y | 1 |
| Shimizu, T | 1 |
| Yamashiro, Y | 1 |
| Coskun, S | 1 |
| Yüksel, H | 1 |
| Onag, A | 1 |
| Butler, R | 1 |
| Stenberg, A | 1 |
| Nevéus, T | 1 |
| Butler, RJ | 1 |
| Cossio, SE | 1 |
| Moore, KH | 1 |
| Sutherst, JR | 1 |
| Choulot, JJ | 1 |
| Mensire, A | 1 |
| Saint Martin, J | 1 |
| Lovering, JS | 1 |
| Tallett, SE | 1 |
| McKendry, JB | 1 |
| Autret, E | 1 |
| Jonville, AP | 1 |
| Furet, Y | 1 |
| Breteau, M | 1 |
| Rosenbaum, D | 1 |
17 reviews available for oxybutynin and Enuresis
| Article | Year |
|---|---|
What do cochrane systematic reviews say about interventions for enuresis in children and adolescents? An overview of systematic reviews.
Topics: Adolescent; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Nocturnal Enuresis; S | 2022 |
Eficácia E Custo-Utilidade De Intervenções Para O Tratamento Da Enurese Em Crianças E Adolescentes Sob A Perspectiva Do Sistema Único De Saúde Brasileiro: Effectiveness and Cost-Utility of Interventions for Enuresis Treatment in Children and Adolescents F
Topics: Adolescent; Brazil; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Tolterodine Tartrate | 2023 |
Nocturnal enuresis: medical management.
Topics: Antidepressive Agents, Tricyclic; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandel | 2004 |
Comparative tolerability of drug treatment for nocturnal enuresis in children.
Topics: Antidepressive Agents, Tricyclic; Carbamazepine; Child; Cyclooxygenase Inhibitors; Deamino Arginine | 2004 |
[Enuresis and benign micturition disorders in childhood. I. Diagnosis and management].
Topics: Child; Deamino Arginine Vasopressin; Enuresis; Humans; Mandelic Acids; Urination Disorders | 1995 |
Diagnosis and management of nocturnal enuresis.
Topics: Age Factors; Behavior Therapy; Child; Circadian Rhythm; Clinical Protocols; Deamino Arginine Vasopre | 1994 |
Older pharmacologic therapy for nocturnal enuresis.
Topics: Adolescent; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipramine; Mandelic Acids; Paras | 1993 |
Nocturnal enuresis. Treatment options.
Topics: Administration, Intranasal; Age Factors; Causality; Child; Deamino Arginine Vasopressin; Diagnosis, | 1993 |
Pathophysiology and impact of nocturnal enuresis.
Topics: Adolescent; Adult; Arousal; Child; Child, Preschool; Combined Modality Therapy; Deamino Arginine Vas | 1997 |
[Drug therapy of enuresis].
Topics: Adrenergic Uptake Inhibitors; Animals; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Imipra | 1996 |
Nocturnal enuresis: a suggestion for a European treatment strategy.
Topics: Age Factors; Antidepressive Agents, Tricyclic; Behavior Therapy; Cholinergic Antagonists; Circadian | 1999 |
Enuresis.
Topics: Adolescent; Child; Child, Preschool; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enures | 2001 |
Treatment of childhood nocturnal enuresis: an examination of clinically relevant principles.
Topics: Behavior Therapy; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Mandelic Acids; Patient Acc | 2001 |
Evidence based management of nocturnal enuresis.
Topics: Antidepressive Agents, Tricyclic; Child; Cholinergic Antagonists; Deamino Arginine Vasopressin; Dicy | 2001 |
Combination therapy for nocturnal enuresis.
Topics: Antidepressive Agents, Tricyclic; Cholinergic Antagonists; Combined Modality Therapy; Deamino Argini | 2001 |
Enuresis.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Child, Preschool; Cholinergic | 2002 |
Successful treatment of nocturnal enuresis: a practical approach.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Defecation; Diet; Enuresis; Female; Follow-Up | 1985 |
11 trials available for oxybutynin and Enuresis
| Article | Year |
|---|---|
Comparison of effects of treatment of primary nocturnal enuresis with oxybutynin plus desmopressin, desmopressin alone or imipramine alone: a randomized controlled clinical trial.
Topics: Adolescent; Child; Child, Preschool; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enures | 2005 |
Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity.
Topics: Adolescent; Biofeedback, Psychology; Child; Child, Preschool; Cholinergic Antagonists; Combined Moda | 2005 |
Urodynamic evaluation in primary enuresis: an investigative and treatment outcome correlation.
Topics: Adolescent; Behavior Therapy; Child; Child, Preschool; Enuresis; Female; Flavoxate; Humans; Imiprami | 2007 |
Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
Topics: Antidepressive Agents, Tricyclic; Antidiuretic Agents; Attention Deficit Disorder with Hyperactivity | 2007 |
Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin.
Topics: Administration, Intranasal; Adolescent; Adult; Analysis of Variance; Child; Child, Preschool; Circad | 1997 |
Effects of systematic treatment based on overnight simultaneous monitoring of electroencephalography and cystometry.
Topics: Adrenergic Uptake Inhibitors; Child; Cholinergic Antagonists; Diagnostic Techniques, Urological; Ele | 1998 |
Combination therapy of imipramine with oxybutynin in children with enuresis nocturna.
Topics: Adolescent; Antidepressive Agents, Tricyclic; Child; Cholinergic Antagonists; Drug Therapy, Combinat | 2000 |
[Results of a therapeutic strategy against monosymptomatic nocturnal enuresis].
Topics: Adolescent; Child; Combined Modality Therapy; Deamino Arginine Vasopressin; Enuresis; Female; Humans | 2001 |
Oxybutynin, desmopressin and enuresis.
Topics: Child; Cholinergic Antagonists; Deamino Arginine Vasopressin; Enuresis; Female; Humans; Male; Mandel | 2001 |
Response to treatment of detrusor instability in relation to psychoneurotic status.
Topics: Colonic Diseases, Functional; Double-Blind Method; Enuresis; Female; Humans; Life Change Events; Man | 1990 |
Oxybutynin efficacy in the treatment of primary enuresis.
Topics: Adolescent; Child; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Enuresis; Female; | 1988 |
25 other studies available for oxybutynin and Enuresis
| Article | Year |
|---|---|
Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.
Topics: Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Enuresis; Female; Humans; Male; Mandelic A | 2021 |
Outcome of a standardized approach to childhood urinary symptoms-long-term follow-up of 720 patients.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidiuretic Agents; Biofeedback, Psychology; Child; Child | 2014 |
Response to Commentary re 'Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis'.
Topics: Antidiuretic Agents; Deamino Arginine Vasopressin; Enuresis; Humans; Mandelic Acids; Nocturnal Enure | 2016 |
Value of increase in bladder capacity in treatment of refractory monosymptomatic nocturnal enuresis in children.
Topics: Administration, Oral; Child; Combined Modality Therapy; Enuresis; Female; Humans; Male; Mandelic Aci | 2002 |
The use of tolterodine in children after oxybutynin failure.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Cross-O | 2003 |
A thirteen-year-old girl with anemia.
Topics: Adolescent; Anemia; Chronic Disease; Constipation; Encopresis; Enuresis; Female; Humans; Mandelic Ac | 2003 |
Nocturnal enuresis in children. A four-year experience in outpatient clinics of pediatric urology.
Topics: Adolescent; Antidiuretic Agents; Behavior Therapy; Benzhydryl Compounds; Chi-Square Distribution; Ch | 2005 |
The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
Topics: Antidiuretic Agents; Child; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enuresis; Human | 2006 |
[Primary enuresis -- combination therapy with oxybutynin plus desmopressin shows good results].
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Antidiuretic Agents; Chi-Square Distribution; Ch | 2007 |
Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
Topics: Adolescent; Adult; Antidiuretic Agents; Child; Child, Preschool; Choice Behavior; Combined Modality | 2007 |
Oxybutynin-associated esotropia.
Topics: Accommodation, Ocular; Child, Preschool; Convergence, Ocular; Enuresis; Esotropia; Female; Humans; M | 2007 |
Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment.
Topics: Blindness; Child, Preschool; Cholinergic Antagonists; Enuresis; Female; Humans; Hypertension; Magnet | 2008 |
Voiding dysfunction in the child with problem "wetting".
Topics: Child; Child, Preschool; Diazepam; Enuresis; Female; Humans; Male; Mandelic Acids; Stress, Physiolog | 1980 |
Comparison of urodynamic findings and response to oxybutynin in nocturnal enuresis.
Topics: Adolescent; Child; Enuresis; Female; Humans; Male; Mandelic Acids; Muscle Contraction; Parasympathol | 1993 |
Bladder dysfunction associated with clozapine therapy.
Topics: Adult; Clozapine; Deamino Arginine Vasopressin; Enuresis; Female; Humans; Male; Mandelic Acids; Para | 1996 |
[Neuropsychiatric adverse effects attributed to use of oxybutynin].
Topics: Aged; Aged, 80 and over; Child; Enuresis; Female; Humans; Male; Mandelic Acids; Mental Disorders; Pa | 1998 |
Evaluation of antidiuretic hormone before and after long-term treatment with desmopressin in a group of enuretic children.
Topics: Adolescent; Child; Cholinergic Antagonists; Deamino Arginine Vasopressin; Drug Therapy, Combination; | 1998 |
Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna--a clinical and urodynamic study.
Topics: Adolescent; Child; Cholinergic Antagonists; Dose-Response Relationship, Drug; Enuresis; Humans; Mand | 1999 |
Effectiveness of treatments for nocturnal enuresis in a heterogeneous population.
Topics: Adolescent; Biofeedback, Psychology; Child; Child, Preschool; Deamino Arginine Vasopressin; Enuresis | 2000 |
[Monosymptomatic nocturnal enuresis: disease or complaint?].
Topics: Child; Child, Preschool; Cholinergic Antagonists; Enuresis; Humans; Male; Mandelic Acids; Self Conce | 2000 |
Nocturnal enuresis.
Topics: Antidepressive Agents, Tricyclic; Child; Combined Modality Therapy; Deamino Arginine Vasopressin; En | 2001 |
Combined pharmacotherapy for nocturnal enuresis.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Benzilates; Child; Cholinergic Antagonists; Drug Th | 2001 |
Is attempting suicide an adverse effect of oxybutynin in a child with enuresis nocturna?
Topics: Child; Cholinergic Antagonists; Drug Overdose; Enuresis; Humans; Male; Mandelic Acids; Suicide, Atte | 2001 |
[Overdose of anticholinergic agents and confusional syndrome].
Topics: Child; Cognition Disorders; Confusion; Enuresis; Humans; Male; Mandelic Acids; Parasympatholytics | 1989 |
[Beware of atropinic drugs in pediatrics!].
Topics: Child; Enuresis; Female; Humans; Mandelic Acids; Parasympatholytics | 1987 |